Vaccines
29 April 2013
Transgene: Promising Final Data from the Phase 2 HCVac Trial of TG4040 Presented at EASL 201329 April 2013
Transgene Presents Promising Pre-Clinical Data on TG1050 to Treat Chronic HBV at EASL 201328 April 2013
Pfizer Presents Phase 3 Safety And Immunogenicity Data On Prevenar 13 In Adults Aged 18 To 49 Years25 April 2013
Immunomic Therapeutics Announces Interim Data Analysis of Phase I Study to Treat Japanese Red Cedar Allergy24 April 2013
Baxter Presents Phase I/II Data Evaluating Lyme Disease Vaccine at NFID Annual Conference on Vaccine Research18 April 2013
Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo18 April 2013
Medicago and IDRI Reports Positive Results for its Phase I Clinical Trial for an H5N1 Vaccine11 April 2013
Early Results of Activartis AV0113 Cancer Immunotherapy in Glioblastoma Trial Reveal Promising TrendNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports